Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
祛瘀止血颗粒治疗排卵障碍性异常子宫出血(黄体功能不足型)(气虚血瘀证)的Ⅱa期临床试验
[Translation] Phase IIa clinical trial of Quyu Zhixue granules in the treatment of abnormal uterine bleeding due to ovulatory dysfunction (luteal insufficiency type) (Qi deficiency and blood stasis syndrome)
以安慰剂为对照初步评价祛瘀止血颗粒对于排卵障碍性异常子宫出血(黄体功能不足型)(气虚血瘀证)月经过多的有效性和安全性,并对其进行剂量探索。
[Translation] Using placebo as a control, the efficacy and safety of Quyu Zhixue Granules for treating ovulatory abnormal uterine bleeding (luteal insufficiency type) (Qi deficiency and blood stasis syndrome) and menorrhagia were preliminarily evaluated, and the dosage was explored.
100 Clinical Results associated with Beijing Shengshi Liangfang Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Shengshi Liangfang Pharmaceutical Technology Co., Ltd.
100 Deals associated with Beijing Shengshi Liangfang Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Beijing Shengshi Liangfang Pharmaceutical Technology Co., Ltd.